🇺🇸 FDA
Pipeline program

Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs)

ACE001-RI001

Phase 1 mab active

Quick answer

Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs) for Interstitial Lung Disease (ILD) is a Phase 1 program (mab) at Shanghai Zhongshan Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai Zhongshan Hospital
Indication
Interstitial Lung Disease (ILD)
Phase
Phase 1
Modality
mab
Status
active

Clinical trials